NCT03684603

Brief Summary

This project aims at gaining insight into the role of sleep in motor learning and the first to apply sleep related learning methods in a rehabilitative setting. The primary objective is to investigate whether there is an effect of acoustic cueing during slow wave sleep on a specific motor task. The second objective is to investigate whether this effect can also be transferred to generalized motor rehabilitation outcome. Patients with an impairment of the arm function are randomized to either receiving the intervention ("cueing group") or to the control group. The patients are all listening to a melody during motor training but only the patients of the cueing group are also exposed to the melody during subsequent slow wave sleep. Performance gain is measured using an instrumented arm orthosis which is used for functional arm therapy over the sudy period of 5 consecutive days as well as during standard clinical assessments.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
12

participants targeted

Target at below P25 for not_applicable stroke

Timeline
Completed

Started Nov 2017

Longer than P75 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2017

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

September 6, 2018

Completed
19 days until next milestone

First Posted

Study publicly available on registry

September 25, 2018

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2020

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2021

Completed
Last Updated

November 20, 2020

Status Verified

November 1, 2020

Enrollment Period

2.6 years

First QC Date

September 6, 2018

Last Update Submit

November 18, 2020

Conditions

Keywords

SleepAcoustic Cueing

Outcome Measures

Primary Outcomes (1)

  • Improvement in specific motor task

    The primary outcome will be the improvement of the task-related scores in the two motor tasks at the ArmeoSpring® device for the first part. The task scores will be provided by the software (ArmeoControl®) itself. The task scores are displayed as an ordinal scale. Higher scores display a better outcome. For the first motor task the scores are displayed as volume in m\^3, for the second one it will be measured in instability in cm and hand-path ratio s unknown variable but with a target value of 1.

    5 days

Secondary Outcomes (2)

  • Correlation of motor learning curve and time of sleep cueing

    5 days

  • Improvement in generalized motor rehabilitation outcome

    5 days

Study Arms (2)

Acoustic cueing

ACTIVE COMPARATOR

The melody will be played during training and during slow wave sleep.

Behavioral: melody during motor training and slow wave sleep

Control

SHAM COMPARATOR

The melody will be played during training.

Behavioral: melody only during motor training

Interventions

sequence of tones which are presented to the patient using earphones

Acoustic cueing

sequence of tones which are presented to the patient using earphones

Control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male and Female patients above 18 years of age
  • signed informed consent after being informed
  • subacute (i.e. symptom onset 3 - 90 days ago) lateralized ischemia or hemorrhage as confirmed by brain imaging (CT or MRI).
  • Fugl-Meyer Upper Extremity Score between 15 and 59

You may not qualify if:

  • other neurological or systemic disorder which is likely to cause dementia, cognitive dysfunction or central motor symptoms
  • severe sensory aphasia
  • preexisting arm paresis
  • intake of sedatives, or neuroleptics
  • Relevant hearing loss
  • Vulnerable Person

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Zurich

Zurich, 8091, Switzerland

Location

MeSH Terms

Conditions

Stroke

Interventions

Sleep, Slow-Wave

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Sleep StagesSleepNervous System Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Christian Baumann, MD

    University Hospital Zurich, Clinic of Neurology

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 6, 2018

First Posted

September 25, 2018

Study Start

November 1, 2017

Primary Completion

June 1, 2020

Study Completion

April 1, 2021

Last Updated

November 20, 2020

Record last verified: 2020-11

Locations